NCT01632371View on ClinicalTrials.gov

Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4

PHASE4CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

November 30, 2016

Conditions
RestenosisStable Angina PectorisAcute Coronary Syndrome
Interventions
DEVICE

Paclitaxel Eluting Balloon + Scoring Balloon

Scoring/cutting balloon lesion predilation; paclitaxel eluting balloon therapy

DEVICE

Paclitaxel Eluting Balloon

Standard balloon lesion predilation; paclitaxel-eluting balloon therapy

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

1. Med. Klinik am Klinikum rechts der Isar der TU Muenchen, Munich

Sponsors

Collaborators (1)

Biotronik AG
All Listed Sponsors
collaborator

Biotronik AG

INDUSTRY

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT01632371 - Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4 | Biotech Hunter | Biotech Hunter